Evaluation of the diagnostic efficiency of voided urine fluorescence in situ hybridization for predicting the pathology of preoperative "low-risk" upper tract urothelial carcinoma

被引:0
|
作者
Xu, Ben [1 ]
Zhang, Jia-En [1 ]
Ye, Lin [1 ]
Yuan, Chang-Wei [1 ]
机构
[1] Peking Univ First Hosp, Dept Urol, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
fluorescence in situ hybridization; upper tract urothelial carcinoma; tumor stage; tumor grade; low-risk; TRANSITIONAL-CELL CARCINOMA; INVASIVE BLADDER-CANCER; PROGNOSTIC-FACTORS; RADICAL NEPHROURETERECTOMY; OUTCOMES; GUIDELINES; SURVIVAL; TUMORS; GRADE; FISH;
D O I
10.3389/fonc.2023.1225428
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectivesTo evaluate the clinical utility of voided urine fluorescence in situ hybridization (FISH) for predicting the pathology of preoperative "low-risk" upper tract urothelial carcinoma (UTUC). MethodsInformation of patients preoperatively diagnosed with "low-risk" UTUC receiving radical nephroureterectomy (RNU) between May 2014 and October 2019 were retrospectively collected. All of the patients accepted the FISH test and then were divided into two groups according to the results of FISH. The diagnostic value of FISH was assessed through the receiver operating characteristics (ROC) curve and area under the curve. Logistic regression analysis was applied to examine FISH as a predictive factor of tumor final stage and grade of preoperative "low-risk" UTUC. ResultsIn total, 129 patients were included. Of them, 70 (54.2%) were marked with positive FISH result. The difference at final pathology in tumor stage and tumor grade between these two groups of FISH (-) and FISH (+) had significantly statistical significance (p<0.001). Regarding to the tumor stage at final pathology, the sensitivity, specificity, positive predictive value and negative predictive value of FISH were 70.7 (58.9-80.3)68.5 (54.3-80.1)75.7 (63.7-84.8) and 62.7 (49.1-74.7), respectively. Regarding to the tumor grade at final pathology, the sensitivity, specificity, positive predictive value and negative predictive value of FISH were 64.7 (53.5-74.6), 65.9 (50.0-79.1), 78.6 (66.8-87.1) and 49.1 (36.5-62.3), respectively. The results of logistic regression analysis indicated that FISH could predict the pathologic characteristics of preoperative "low-risk" UTUC independently. ConclusionsFISH was qualified with relatively high diagnostic estimates for predicting tumor stage and grade of preoperative "low-risk" UTUC, and could be an independent predictive factor in clinical practice. For preoperative "low-risk" UTUC patients but with positive FISH result, choosing nephron-sparing surgery may require special caution.
引用
收藏
页数:7
相关论文
共 44 条
  • [21] Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis
    Amir Hossein Aalami
    Farnoosh Aalami
    International Journal of Clinical Oncology, 2022, 27 : 1605 - 1615
  • [22] Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy
    Liu, Wen
    Wang, Zhankun
    Liu, Shuai
    Yao, Yu
    Liu, Yong
    Zhang, Guiming
    BMC CANCER, 2020, 20 (01)
  • [23] Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy
    Wen Liu
    Zhankun Wang
    Shuai Liu
    Yu Yao
    Yong Liu
    Guiming Zhang
    BMC Cancer, 20
  • [24] Radical therapy for low-risk upper tract urothelial carcinoma (ROBUUST collaborative group)
    Corsi, N.
    Pandolfo, S.
    Eilender, B. M.
    Bell, S. H.
    Wang, L.
    Tuderti, G.
    Ghoreifi, A.
    Tozzi, M.
    Taylor, J.
    Dhanji, S.
    Yong, C.
    Checcucci, E.
    Derweesh, I. H.
    Eun, D. D.
    Porpiglia, F.
    Gonzalgo, M. L.
    Mehrazin, R.
    Simone, G.
    Ferro, M.
    Margulis, V.
    Sundaram, C. P.
    Djaladat, H.
    Wu, Z.
    Autorino, R.
    Abdollah, F.
    EUROPEAN UROLOGY, 2023, 83
  • [25] RADICAL THERAPY FOR LOW-RISK UPPER TRACT UROTHELIAL CARCINOMA (ROBUUST COLLABORATIVE GROUP)
    Corsi, Nick
    Morrison, Chase
    Davis, Matthew
    Stephens, Alex
    Rogers, Devin
    Tuderti, Gabriele
    Mendiola, Dinno F.
    Wang, Linhui
    Checcucci, Enrico
    Bell, Spencer H.
    Yong, Courtney
    Dhanji, Sohail
    Hakimi, Kevin
    Taylor, Jacob
    Wood, Erika
    Ghoreifi, Alireza
    Tozzi, Marco
    Eilender, Benjamin M.
    Sundaram, Chandru
    Derweesh, Ithaar H.
    Margulis, Vitaly
    Ferro, Matteo
    Simone, Giuseppe
    Mehrazin, Reza
    Gonzalgo, Mark L.
    Djaladat, Hooman
    Porpiglia, Francesco
    Eun, Daniel D.
    Wu, Zhenjie
    Autorino, Riccardo
    Abdollah, Firas
    JOURNAL OF UROLOGY, 2023, 209 : E538 - E538
  • [26] Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma
    Marin-Aguilera, Mercedes
    Menqual, Lourdes
    Ribal, Maria Jose
    Musquera, Mireia
    Ars, Elisabet
    Villauicencio, Humberto
    Alyaba, Ferran
    Alcaraz, Antonio
    EUROPEAN UROLOGY, 2007, 51 (02) : 409 - 415
  • [27] FLUORESCENCE IN SITU HYBRIDIZATION (FISH) IN THE DIAGNOSIS OF BLADDER AND UPPER TRACT UROTHELIAL CARCINOMA: A SINGLE-INSTITUTION EXPERIENCE
    Mann, Mark
    Cleary, Ryan
    Gomella, Leonard
    Hubosky, Scott
    McCue, Peter
    Bagley, Demetrius
    Lallas, Costas
    Trabulsi, Edouard
    JOURNAL OF UROLOGY, 2016, 195 (04): : E299 - E299
  • [28] Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma
    Lu, Huan
    Liang, Yuan
    Guan, Bao
    Shi, Yue
    Gong, Yanqing
    Li, Juan
    Kong, Wenwen
    Liu, Jin
    Fang, Dong
    Liu, Libo
    He, Qun
    Shakeel, Muhammad
    Li, Xuesong
    Zhou, Liqun
    Ci, Weimin
    THERANOSTICS, 2020, 10 (10): : 4323 - 4333
  • [29] Multiple Fluorescences in Situ Hybridization Status in Excreted Urine Improve Diagnostic Efficacy for Upper Urinary Tract Urothelial Carcinomas
    Tang, Feng
    Wang, Xia
    Liu, Tao
    Wang, Hao
    Wan, Ziyu
    Fu, Qiqi
    Zheng, Zhangjie
    Aersi, Madanyeti
    Peng, Jianping
    UROLOGY JOURNAL, 2024, 21 (02) : 107 - 113
  • [30] Time to safely omit bladder cuff removal for low-risk upper tract urothelial carcinoma
    Abrate, Alberto
    Vella, Marco
    Mogorovich, Andrea
    Giaimo, Rosa
    Serretta, Vincenzo
    Vone, Carlo Pa
    Bartoletti, Riccardo
    Simonato, Alchiede
    MINERVA UROLOGY AND NEPHROLOGY, 2021, 73 (04): : 417 - 420